181 related articles for article (PubMed ID: 20190028)
1. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.
Nascimento MM; Suliman ME; Silva M; Chinaglia T; Marchioro J; Hayashi SY; Riella MC; Lindholm B; Anderstam B
Perit Dial Int; 2010; 30(3):336-42. PubMed ID: 20190028
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral N-acetylcysteine treatment on immune system in continuous ambulatory peritoneal dialysis patients.
Purwanto B; Prasetyo DH
Acta Med Indones; 2012 Apr; 44(2):140-4. PubMed ID: 22745145
[TBL] [Abstract][Full Text] [Related]
3. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.
Saddadi F; Alatab S; Pasha F; Ganji MR; Soleimanian T
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):66-72. PubMed ID: 24434384
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study to Evaluate the Effects of Oral N-Acetyl Cysteine on Inflammatory and Oxidative Stress Biomarkers in Rheumatoid Arthritis.
Hashemi G; Mirjalili M; Basiri Z; Tahamoli-Roudsari A; Kheiripour N; Shahdoust M; Ranjbar A; Mehrpooya M; Ataei S
Curr Rheumatol Rev; 2019; 15(3):246-253. PubMed ID: 30255760
[TBL] [Abstract][Full Text] [Related]
5. The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
Skov M; Pressler T; Lykkesfeldt J; Poulsen HE; Jensen PØ; Johansen HK; Qvist T; Kræmer D; Høiby N; Ciofu O
J Cyst Fibros; 2015 Mar; 14(2):211-8. PubMed ID: 25458464
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
7. The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.
Skvarc DR; Dean OM; Byrne LK; Gray LJ; Ives K; Lane SE; Lewis M; Osborne C; Page R; Stupart D; Turner A; Berk M; Marriott AJ
Trials; 2016 Aug; 17():395. PubMed ID: 27502769
[TBL] [Abstract][Full Text] [Related]
8. The effects of N-acetylcysteine on inflammatory and oxidative stress biomarkers: A systematic review and meta-analysis of controlled clinical trials.
Faghfouri AH; Zarezadeh M; Tavakoli-Rouzbehani OM; Radkhah N; Faghfuri E; Kord-Varkaneh H; Tan SC; Ostadrahimi A
Eur J Pharmacol; 2020 Oct; 884():173368. PubMed ID: 32726657
[TBL] [Abstract][Full Text] [Related]
9. Effect of N-Acetylcysteine on Metabolic Profile in Metabolic Syndrome Patients.
Rani M; Aggarwal R; Vohra K
Metab Syndr Relat Disord; 2020 Sep; 18(7):341-346. PubMed ID: 32552298
[No Abstract] [Full Text] [Related]
10. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
Nolin TD; Ouseph R; Himmelfarb J; McMenamin ME; Ward RA
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1588-94. PubMed ID: 20538838
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral N-acetylcysteine on walking capacity, leg reactive hyperemia, and inflammatory and angiogenic mediators in patients with intermittent claudication.
da Silva ND; Roseguini BT; Chehuen M; Fernandes T; Mota GF; Martin PK; Han SW; Forjaz CL; Wolosker N; de Oliveira EM
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H897-905. PubMed ID: 26116711
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial.
Zhang Q; Ju Y; Ma Y; Wang T
Medicine (Baltimore); 2018 Nov; 97(45):e13087. PubMed ID: 30407312
[TBL] [Abstract][Full Text] [Related]
13. Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients.
Thaha M; Widodo ; Pranawa W; Yogiantoro M; Tomino Y
Clin Nephrol; 2008 Jan; 69(1):24-32. PubMed ID: 18226399
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis induces p66(shc) gene expression in nondiabetic humans: correlations with oxidative stress and systemic inflammation.
Zanetti M; Barazzoni R; Gortan Cappellari G; Burekovic I; Bosutti A; Stocca A; Bianco F; Ianche M; Panzetta G; Guarnieri G
J Ren Nutr; 2011 Sep; 21(5):401-9. PubMed ID: 21439852
[TBL] [Abstract][Full Text] [Related]
15. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B
Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541
[TBL] [Abstract][Full Text] [Related]
16. Elevated Plasma Cyclophillin A in Hemodialysis and Peritoneal Dialysis Patients: a Novel Link to Systemic Inflammation.
Jin K; Vaziri ND
Iran J Kidney Dis; 2017 Jan; 11(1):44-49. PubMed ID: 28174352
[TBL] [Abstract][Full Text] [Related]
17. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
[TBL] [Abstract][Full Text] [Related]
18. Intravenous N-acetylcysteine with saline hydration improves renal function and ameliorates plasma total homocysteine in patients undergoing cardiac angiography.
Wang JH; Subeq YM; Tsai WC; Lee RP; Hsu BG
Ren Fail; 2008; 30(5):527-33. PubMed ID: 18569934
[TBL] [Abstract][Full Text] [Related]
19. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
